Reuters logo
BRIEF-SELEXIS SA AND PELICAN THERAPEUTICS SIGN AGREEMENT TO ADVANCE PELICAN’S IMMUNOTHERAPY CLINICAL PROGRAMS
October 4, 2017 / 12:47 PM / 16 days ago

BRIEF-SELEXIS SA AND PELICAN THERAPEUTICS SIGN AGREEMENT TO ADVANCE PELICAN’S IMMUNOTHERAPY CLINICAL PROGRAMS

Oct 4 (Reuters) - Selexis SA:

* SELEXIS SA AND PELICAN THERAPEUTICS SIGN AGREEMENT TO ADVANCE PELICAN’S IMMUNOTHERAPY CLINICAL PROGRAMS

* SELEXIS SA - CO, PELICAN THERAPEUTICS ENTERED INTO SERVICE AGREEMENT TO ADVANCE DEVELOPMENT OF PELICAN‘S PROPRIETARY IMMUNOTHERAPY CLINICAL CANDIDATES Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below